How red light therapy inhibits chronic inflammation at the cellular level. Scientifically substantiated with clinical studies.

Chronic inflammation plays a central role in numerous conditions, from joint pain and autoimmune diseases to cardiovascular diseases and accelerated aging. Red light therapy offers a scientifically proven method to modulate inflammatory processes at the cellular level, without the side effects of long-term medication use.

How does red light therapy inhibit inflammation?

At the cellular level, photobiomodulation works through various mechanisms. It inhibits the production of pro-inflammatory cytokines such as TNF-alpha and IL-6, which are responsible for sustaining chronic inflammation. It stimulates the production of anti-inflammatory mediators. And it modulates the activity of immune cells, creating a healthier balance between pro- and anti-inflammatory responses.

Scientific Basis

An extensive review in AIMS Biophysics by Hamblin (2017) describes how wavelengths in the red and near-infrared spectrum (650-950 nm) activate anti-inflammatory effects at dosages of 1-10 J/cm2. A comprehensive review in PMC (2024) on the immunomodulatory effects of photobiomodulation confirms that this therapy can restore the balance between pro- and anti-inflammatory responses.

The eight wavelengths of the ATP Pro series, including 630 nm, 660 nm, and 850 nm, cover the entire therapeutic window. The higher wavelengths (940 nm, 1060 nm, and 1072 nm) add extra depth penetration for inflammation in deeper tissues.

Hamblin, M.R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics.

Immunomodulatory effects of photobiomodulation: a comprehensive review (PMC, 2024)